Surgical cytoreduction in stage IV endometrioid endometrial carcinoma

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 608-611

  Shih, K K ^a   Yun, E ^a   Gardner, G J ^a   Barakat, R R ^a   Chi, D S ^a   Leitao Jr , M M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrioid endometrial carcinoma; Stage IV endometrial cancer; Surgical cytoreduction

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MEDROXYPROGESTERONE; MEGESTROL; NAVELBINE; PACLITAXEL; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 80051550748     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.020     Document Type: Article

References (15)

1. A. Jemal Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
2. B.A. Goff Surgical stage IV endometrial carcinoma: a study of 47 cases Gynecol Oncol 52 2 1994 237 240 (Pubitemid 24064377)
3. D.S. Chi The role of surgical cytoreduction in Stage IV endometrial carcinoma Gynecol Oncol 67 1 1997 56 60 (Pubitemid 27433329)
4. R.E. Bristow Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival Gynecol Oncol 78 2 2000 85 91 (Pubitemid 30650336)
5. D.S. Chi, and R.R. Barakat Surgical management of advanced or recurrent endometrial cancer Surg Clin North Am 81 4 2001 885 896 (Pubitemid 33127065)
6. A. Ayhan The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer Int J Gynecol Cancer 12 5 2002 448 453
7. N.C. Lambrou Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival Gynecol Oncol 93 3 2004 653 658 (Pubitemid 38766051)
8. F.H. van Wijk Stage III and IV endometrial cancer: a 20-year review of patients Int J Gynecol Cancer 16 4 2006 1648 1655 (Pubitemid 44060393)
9. R. Numazaki Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients Int J Clin Oncol 14 4 2009 344 350
10. L.M. Landrum Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis Gynecol Oncol 112 2 2009 337 341
11. J.N. Barlin, I. Puri, and R.E. Bristow Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis Gynecol Oncol 118 2010 14 18
12. J.L. Benedet FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2 2000 209 262
13. D.S. Chi Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol 94 3 2004 650 654 (Pubitemid 39194456)
14. M.E. Randall Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 1 2006 36 44 (Pubitemid 46630491)
15. G.F. Fleming Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 22 11 2004 2159 2166 (Pubitemid 41095150)